Business Wire

TNS Targets Global Growth with Strategic Acquisition of AGNITY Global

Share

Transaction Network Services (TNS) has today announced the acquisition of AGNITY Global, a leading provider of intelligent business communication applications and infrastructure to organizations in the telecommunications and healthcare industry verticals.

The move strategically enhances TNS’ Communications Market global capabilities through AGNITY’s established channel partnerships business model that spans more than 12 countries. It will also enable TNS’ existing customers to benefit from a broader portfolio of next generation solutions.

Headquartered in Silicon Valley with development and support operations in Richardson, Texas and Noida, India, AGNITY powers the networks of many global Tier-1 service providers via its scalable, carrier-grade Communication Application Server (CAS). This network agnostic, multi-service software platform offers app components and open APIs that enable service providers to address network technology transition challenges as well as future-proofing their infrastructure to more rapidly introduce new services.

“AGNITY is a perfect strategic fit for TNS as we seek to invest in and evolve our carrier service offerings, channel partnerships and development capabilities,” said Bill Versen, President of TNS’ Communications Market business. “Combining AGNITY’s innovative technology with our proven solutions creates a superior portfolio that will enable us to help carriers modernize their networks and bridge legacy platforms with new technology, including 5G enablement services.”

Founded in 2008 by tech entrepreneur and CEO Sanjeev Chawla, AGNITY boasts 5G ready technology and has more than 30 out-of-the-box high value applications, including advanced call routing, evolved next gen intelligent networks and fraud protection. AGNITY’s Defend application combines call screening and audio CAPTCHA with a range of CDR, speech and biometric analysis to identify, filter and block fraudulent calls as required. AGNITY FlexYcharge service is a real-time rating, charging and balance management service for voice, data, messaging across VoIP, IMS and Legacy networks.

“Our objective has always been to facilitate telecom network transformation through efficient, future-proofed applications and adoption of the latest technologies,” said Mr. Chawla, who is remaining with the company as Chief Technology Officer for TNS’ Communications Market business, reporting to Mr. Versen. “Creating the AGNITY CAS, a single platform for legacy, LTE/IMS, 5G and Cloud hosted networks, has brought significant revenue opportunities, efficiency gains and operational cost reduction to our customers. Now, as part of TNS’ large and established footprint, we look forward to bringing our joint capabilities to a wider audience.”

“We are excited to have Sanjeev and his talented team on board,” added Versen. “Sanjeev will play a major role in the development of TNS as we drive forward with our long-term growth vision, including the introduction of our award-winning identity and protection solutions to the global marketplace. We will also now be able to conduct near 24/7 development with resources in the US and India focused on innovating and rolling out our products faster than ever before.”

TNS, a subsidiary of Koch Equity Development, is a leading global provider of Infrastructure-as-a-Service solutions to the communications, payments and financial markets. Its pioneering Communications Market business has been a continuous innovator interconnecting carrier networks efficiently, securely and reliably. Its solutions range from call analytics, which identifies unwanted robocalls while enabling enhanced mobile identity for legitimate callers, to interoperability, mobile roaming, clearing and settlement, and analytics for LTE and 5G.

Terms of the deal were not disclosed.

About Transaction Network Services
Established more than 30 years ago, TNS’ extensive portfolio of innovative, value-added services now supports thousands of organizations across more than 60 countries to interact efficiently, conduct mission critical processes securely and adopt new technologies flexibly. For more information, please visit tnsi.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Company:
TNS
Clare Cockroft
703-814-8065
pr@tnsi.com

Or

Media:
Bluetext for TNS
Brian Lustig
202-836-9112
tns@bluetext.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye